美股A股
StockGist

STERIS plc

STENYSE · Healthcare · Medical - Devices
STERIS plc provides infection prevention and other procedural products and services worldwide.
$264.32+4.29%
报价 2026-11-13
市值
$25.67B
EV
$26.4B
PE (TTM)
30.3x
预期 PE (FY2027)
23.2x
52 周区间距高点 -1.6%
$199.40$268.65

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Medical - Devices
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
STESTERIS plc$25.67B+4.3%+7.3%44.7%30.3x17.2x26.6x
EWEdwards Lifesciences Corporation$61.61B+1.3%+12.7%78.1%44.5x32.6x43.3xGARP
DXCMDexCom, Inc.$31.08B+2.4%+12.4%63.4%34.4x21.8x23.9xGARP
PHGKoninklijke Philips N.V.$29.47B+1.0%–45.2%24.5x10.1x–
ZBHZimmer Biomet Holdings, Inc.$19.53B-1.3%+4.9%71.2%27.1x12.0x12.3x
GKOSGlaukos Corporation$14.55B-0.1%+56.0%85.2%––392.4x高增长
SNNSmith & Nephew plc$13.09B+0.9%–68%22.0x10.3x–
PENPenumbra, Inc.$12.65B+0.0%+15.9%67.1%74.0x59.0x63.1x
ALGNAlign Technology, Inc.$11.86B+0.8%+2.6%68.7%25.0x14.9x20.1x
同行中位数––+12.6%68.4%27.1x14.9x33.6x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q2 2027
2026-06-30
Q1 2027
2026-03-31
Q4 2026
2025-12-31
Q3 2026
2025-09-30
Q2 2026
2025-06-30
Q1 2026
2025-03-31
Q4 2025
2024-12-31
Q3 2025
Revenue$1.59B$1.49B$1.59B$1.5B$1.46B$1.39B$1.48B$1.37B
Gross Margin44.7%45.8%43.9%43.8%44.2%45.1%43.3%44.5%
Operating Margin18.5%19.1%19.9%18.1%18.4%17.7%14.6%17.9%
Net Income$213.7M$200.1M$220.3M$192.8M$191.9M$177.4M$145.7M$173.5M
Diluted EPS2.192.042.241.961.941.791.481.75
Operating Cash Flow$288.8M$367.1M$335.4M$298.2M$287.8M$420M$260.8M$332.8M

研究材料